4//SEC Filing
Esperion Therapeutics, Inc. 4
Accession 0001179110-17-002987
$ESPRCIK 0001434868operating
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 6:48 PM ET
Size
5.4 KB
Accession
0001179110-17-002987
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2017-02-21+10,800→ 10,800 totalExercise: $24.42Exp: 2027-02-21→ Common Stock (10,800 underlying)
Footnotes (1)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on May 21, 2017.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434868
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 6:48 PM ET
- Size
- 5.4 KB